The COVID-19 vaccination campaign is to start in Ukraine in February.
Ukrainian Deputy Health Minister, Chief Medical Officer Viktor Liashko has said the U.S.-based Pfizer company will soon submit documents for the registration of a vaccine against COVID-19 in Ukraine.
The Health Ministry on February 4 had a phone call with the Pfizer headquarters, he said.
"We've received assurances that all documents for the registration of the Pfizer vaccine in Ukraine will be submitted in the near future. The vaccine will be used in Ukraine when it is properly registered," Liashko said during an online briefing on Friday, an UNIAN correspondent reported.
"The COVID-19 vaccination campaign will start in Ukraine in February. It will be voluntary and free [for the at-risk groups]. In February, Ukraine will receive the first tranche of the vaccine under the COVAX Facility, which is 117,000 doses of an mRNA vaccine from the U.S. producer Pfizer. This vaccine will be immediately distributed for the vaccination of healthcare workers, as well as employees of healthcare institutions working with coronavirus patients," he said.
Liashko reiterated a law allowing the fast-track registration of a COVID-19 vaccine was passed by lawmakers and enacted by the president.
COVAX is a global initiative created by the Global Alliance for Vaccines and Immunization (GAVI) to accelerate the development, production, and equal access to tests, treatment and vaccines against COVID-19.
Read alsoSeveral EU countries agree to sell surplus COVID-19 vaccines to Ukraine – Deputy PM